WO1994008586A3 - Derives azido de l'acide heptanoique ou heptenoique de cyclopentane - Google Patents
Derives azido de l'acide heptanoique ou heptenoique de cyclopentane Download PDFInfo
- Publication number
- WO1994008586A3 WO1994008586A3 PCT/US1993/009769 US9309769W WO9408586A3 WO 1994008586 A3 WO1994008586 A3 WO 1994008586A3 US 9309769 W US9309769 W US 9309769W WO 9408586 A3 WO9408586 A3 WO 9408586A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyclopentane
- azido
- heptenoic acid
- cyclopentane heptanoic
- azido derivatives
- Prior art date
Links
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 title abstract 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 title abstract 3
- YURNCBVQZBJDAJ-UHFFFAOYSA-N 2-heptenoic acid Chemical compound CCCCC=CC(O)=O YURNCBVQZBJDAJ-UHFFFAOYSA-N 0.000 title abstract 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 title abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 2
- PRLVHZDMICRVJF-UHFFFAOYSA-N cyclopentane;heptanoic acid Chemical compound C1CCCC1.CCCCCCC(O)=O PRLVHZDMICRVJF-UHFFFAOYSA-N 0.000 abstract 2
- 208000021822 hypotensive Diseases 0.000 abstract 2
- 230000001077 hypotensive effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention a trait à de nouveaux dérivés d'acide heptanoïque et hepténoïque de cyclopentane 2-aliphatique ou arylaliphatique qui comprennent au moins un substituant azido. On décrit notamment des acides heptanoïques et hepténoïques de cyclopentane 2-aliphatiques ou arylaliphatiques et certains de leurs esters, substitués en position 3 et/ou 5 du cycle cyclopentane avec des radicaux choisis dans le groupe consistant en hydroxy, azido et leurs mélanges. Ces composés azido sont utiles comme hypotenseurs oculaires et comme intermédiaires servant à préparer d'autres composés utiles comme hypotenseurs oculaires.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU53583/94A AU5358394A (en) | 1992-10-16 | 1993-10-13 | Azido derivatives of cyclopentane heptanoic or heptenoic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/962,179 | 1992-10-16 | ||
US07/962,179 US5332730A (en) | 1992-10-16 | 1992-10-16 | Azido derivatives of cyclopentane heptanoic or heptenoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994008586A2 WO1994008586A2 (fr) | 1994-04-28 |
WO1994008586A3 true WO1994008586A3 (fr) | 1994-05-26 |
Family
ID=25505516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/009769 WO1994008586A2 (fr) | 1992-10-16 | 1993-10-13 | Derives azido de l'acide heptanoique ou heptenoique de cyclopentane |
Country Status (3)
Country | Link |
---|---|
US (1) | US5332730A (fr) |
AU (1) | AU5358394A (fr) |
WO (1) | WO1994008586A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
TR200000671T2 (tr) * | 1997-09-09 | 2000-07-21 | The Procter & Gamble Company | FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler. |
SK3382000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders |
NZ513825A (en) | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US8722739B2 (en) * | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3935241A (en) * | 1974-05-10 | 1976-01-27 | Syntex (U.S.A.) Inc. | 11α-METHYLSUBSTITUTED PROSTAGLANDIN DERIVATIVES |
US4097489A (en) * | 1977-06-17 | 1978-06-27 | The Upjohn Company | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds |
EP0093380A2 (fr) * | 1982-05-03 | 1983-11-09 | The Trustees Of Columbia University In The City Of New York | L'application d'eicosanoides et leurs dérivés pour le traitement de l'hypertension oculaire et le glaucome |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2721414B2 (ja) * | 1988-09-06 | 1998-03-04 | フアーマシア・アンド・アツプジヨン・アー・ベー | 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体 |
US5034413A (en) * | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
-
1992
- 1992-10-16 US US07/962,179 patent/US5332730A/en not_active Expired - Fee Related
-
1993
- 1993-10-13 AU AU53583/94A patent/AU5358394A/en not_active Abandoned
- 1993-10-13 WO PCT/US1993/009769 patent/WO1994008586A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3935241A (en) * | 1974-05-10 | 1976-01-27 | Syntex (U.S.A.) Inc. | 11α-METHYLSUBSTITUTED PROSTAGLANDIN DERIVATIVES |
US4097489A (en) * | 1977-06-17 | 1978-06-27 | The Upjohn Company | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds |
EP0093380A2 (fr) * | 1982-05-03 | 1983-11-09 | The Trustees Of Columbia University In The City Of New York | L'application d'eicosanoides et leurs dérivés pour le traitement de l'hypertension oculaire et le glaucome |
Non-Patent Citations (1)
Title |
---|
G. L. BUNDY ET AL.: "THE SYNTHESIS OF NITROGEN-CONTAINING PROSTACYCLIN ANALOGS.", TETRAHEDRON LETTERS, vol. 16, 1978, OXFORD GB, pages 1371 - 1374, XP000957084, DOI: doi:10.1016/S0040-4039(01)94548-4 * |
Also Published As
Publication number | Publication date |
---|---|
WO1994008586A2 (fr) | 1994-04-28 |
AU5358394A (en) | 1994-05-09 |
US5332730A (en) | 1994-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2031384A1 (fr) | Concentres du composant actif et nouvelles combinaisons du composant actif des feuilles de ginkgo biloba, mode de fabrication, et produits pharmaceutiques contenant lesdit | |
EP1227091A3 (fr) | Intermédiaires de formamide pour la préparation d'imidazoles à tri-substitution ayant des propriétés thérapeutiques multiples | |
CA2146852A1 (fr) | Nouveaux derives de substitution du pyrazole; methode de preparation; utilisation comme herbicides | |
CA2180008A1 (fr) | Acides cyclopentane(ene) heptenoiques ou heptanoiques et leurs derives utiles comme agents therapeutiques | |
AU6194894A (en) | Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
AU7672294A (en) | Compositions and methods for the administration of delta-aminolevulinic acid | |
CA2174494A1 (fr) | Benzofuranes | |
AU5174596A (en) | Fatty acid based compositions and methods for the control of plant infections and pests | |
CA2188580A1 (fr) | Heterocycles n-cyanoaryle-azote | |
WO1994008586A3 (fr) | Derives azido de l'acide heptanoique ou heptenoique de cyclopentane | |
WO1992008465A3 (fr) | 2-decarboxyle-2-aminoalkyle-prostagladines comme agents hypotensifs oculaires | |
AU1277397A (en) | Steroid nitrite ester derivatives useful as anti-inflammatory drugs | |
KR0148213B1 (en) | Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same | |
CA2041818A1 (fr) | Separation des enantiomeres du cimaterol, (-)-cimaterol et leur usage comme composes pharmaceutiques ou comme stimulateurs du rendement | |
WO1995011682A3 (fr) | Acide heptanoique ou heptenoique cyclopentanique, 2-arylalkyle ou arylalcenyle et derives de ces derniers utilises comme agents therapeutiques | |
AU7166094A (en) | Process for the hydroformylation of 1,3-butadiene | |
CA2003379A1 (fr) | Emulsion lipidique stabilisee par un derive polysaccharidique | |
AU3408493A (en) | Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha,beta-unsaturated oxime and an aminobutenedioate | |
EP0367489A3 (fr) | Matériaux antithrombosiques et leur méthode de préparation | |
CA2047802A1 (fr) | Compositions pharmaceutiques | |
EP0402923A3 (fr) | 2,5-Diamino-tétralines, leur procédé de préparation et leur utilisation comme médicament | |
CA2263846A1 (fr) | Nouveaux derives de pyranoside | |
AU5316194A (en) | New 17,20-epoxide derivatives of pregnane, their preparation, their use in the preparation of cortisone derivatives and intermediates | |
AU3709689A (en) | Substituted 4-sulphonylamino-2-azinyl-1,2,4-traizol-3-ones, processes and intermediates for their preparation and their use as herbicides | |
AU9142091A (en) | Process for the preparation of derivatives of 3,5-dihydroxy pentanoic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA HU JP NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA HU JP NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |